Search research articles
Contact Us
Filters
Showing results (141-150 of 170) with videos related to
Page
of 17
Sort By:
Cancer Medicine
|
October 6, 2022
Clinical impact of early response to first-line VEGFR-TKI in patients with metastatic renal cell carcinoma on survival: A multi-institutional retrospective study
Ryuta Sobu, Kazuyuki Numakura, Sei Naito, et al.
Journal of Radiation Research
|
April 12, 2023
A Japanese registry study and systematic review of particle therapy for renal cell carcinoma
Hitoshi Ishikawa, Takeshi Arimura, Kazushi Maruo, et al.
The World Journal of Men'S Health
|
March 11, 2022
Firmicutes in Gut Microbiota Correlate with Blood Testosterone Levels in Elderly Men
Makoto Matsushita, Kazutoshi Fujita, Daisuke Motooka, et al.
International Journal of Clinical Oncology
|
June 21, 2019
Nivolumab in patients with unresectable locally advanced or metastatic urothelial carcinoma: CheckMate 275 2-year global and Japanese patient population analyses
Chikara Ohyama, Takahiro Kojima, Tsunenori Kondo, et al.
Journal of Human Genetics
|
November 16, 2012
Impact of four loci on serum tamsulosin hydrochloride concentration
Ryo Takata, Koichi Matsuda, Jun Sugimura, et al.
BMC Cancer
|
October 3, 2013
Impacts of clinicopathologic and operative factors on short-term and long-term survival in renal cell carcinoma with venous tumor thrombus extension: a multi-institutional retrospective study in Japan
Masanori Hirono, Mikio Kobayashi, Tomoyasu Tsushima, et al.
Journal of Clinical Medicine
|
February 13, 2026
Clinical Impact of Preoperative Obesity on Living-Donor Kidney Transplant Recipients in Japan: A Multicenter Experience
Ryohei Yamamoto, Mitsuru Saito, Ryuichiro Sagehashi, et al.
Clinical Genitourinary Cancer
|
May 30, 2020
Sunitinib Versus Sorafenib as Initial Targeted Therapy for mCC-RCC With Favorable/Intermediate Risk: Multicenter Randomized Trial CROSS-J-RCC
Yoshihiko Tomita, Sei Naito, Naoto Sassa, et al.
Cancer Science
|
December 29, 2019
Avelumab plus axitinib vs sunitinib for advanced renal cell carcinoma: Japanese subgroup analysis from JAVELIN Renal 101
Motohide Uemura, Yoshihiko Tomita, Hideaki Miyake, et al.
International Journal of Clinical Oncology
|
June 30, 2021
Prognosis of Japanese metastatic renal cell carcinoma patients in the targeted therapy era
Sei Naito, Tomoyuki Kato, Kazuyuki Numakura, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 170) with videos related to
Sort By:
Page
of 17
Cancer Medicine
|
October 6, 2022
Clinical impact of early response to first-line VEGFR-TKI in patients with metastatic renal cell carcinoma on survival: A multi-institutional retrospective study
Ryuta Sobu, Kazuyuki Numakura, Sei Naito, et al.
Journal of Radiation Research
|
April 12, 2023
A Japanese registry study and systematic review of particle therapy for renal cell carcinoma
Hitoshi Ishikawa, Takeshi Arimura, Kazushi Maruo, et al.
The World Journal of Men'S Health
|
March 11, 2022
Firmicutes in Gut Microbiota Correlate with Blood Testosterone Levels in Elderly Men
Makoto Matsushita, Kazutoshi Fujita, Daisuke Motooka, et al.
International Journal of Clinical Oncology
|
June 21, 2019
Nivolumab in patients with unresectable locally advanced or metastatic urothelial carcinoma: CheckMate 275 2-year global and Japanese patient population analyses
Chikara Ohyama, Takahiro Kojima, Tsunenori Kondo, et al.
Journal of Human Genetics
|
November 16, 2012
Impact of four loci on serum tamsulosin hydrochloride concentration
Ryo Takata, Koichi Matsuda, Jun Sugimura, et al.
BMC Cancer
|
October 3, 2013
Impacts of clinicopathologic and operative factors on short-term and long-term survival in renal cell carcinoma with venous tumor thrombus extension: a multi-institutional retrospective study in Japan
Masanori Hirono, Mikio Kobayashi, Tomoyasu Tsushima, et al.
Journal of Clinical Medicine
|
February 13, 2026
Clinical Impact of Preoperative Obesity on Living-Donor Kidney Transplant Recipients in Japan: A Multicenter Experience
Ryohei Yamamoto, Mitsuru Saito, Ryuichiro Sagehashi, et al.
Clinical Genitourinary Cancer
|
May 30, 2020
Sunitinib Versus Sorafenib as Initial Targeted Therapy for mCC-RCC With Favorable/Intermediate Risk: Multicenter Randomized Trial CROSS-J-RCC
Yoshihiko Tomita, Sei Naito, Naoto Sassa, et al.
Cancer Science
|
December 29, 2019
Avelumab plus axitinib vs sunitinib for advanced renal cell carcinoma: Japanese subgroup analysis from JAVELIN Renal 101
Motohide Uemura, Yoshihiko Tomita, Hideaki Miyake, et al.
International Journal of Clinical Oncology
|
June 30, 2021
Prognosis of Japanese metastatic renal cell carcinoma patients in the targeted therapy era
Sei Naito, Tomoyuki Kato, Kazuyuki Numakura, et al.
Page
of 17